期刊文献+

维持性血液透析患者蛋白质能量消耗营养评估方式的研究进展 被引量:7

A review of nutritional screening and assessment tools for protein-energy wasting in maintenancehemodialysis patients
下载PDF
导出
摘要 维持性血液透析患者(MHD)大多存在蛋白质能量消耗(PEW)。PEW是MHD患者死亡的独立危险因素,与MHD患者的不良预后及生活质量密切相关。PEW的发生机制目前尚不清楚。文章通过对既往涉及PEW评估文献进行回顾与分析,主要通过单因素和多因素评估指标对目前常用的评估方式及其各自优劣进行综述。 Most of the maintenance hemodialysis patients(MHD)have a risk of protein energy waste(PEW).PEW is not only an independent risk factor for death,but also closely related to poor prognosis and quality of life in patients with MHD.At present,the mechanism of PEW is still unknown,so there are many ways to screen and assess it.This paper reviews the commonly used evaluation tools and their respective advantages and disadvantages through single and multiple factors.
作者 戴选彤 蒋更如 DAI Xuan-tong;JIANG Geng-ru(Department of Nephrology,Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine,Shanghai 200092,China)
出处 《医学研究生学报》 CAS 北大核心 2018年第10期1100-1104,共5页 Journal of Medical Postgraduates
基金 上海市科学技术委员会科研计划项目(15441903504)
关键词 维持性血液透析 蛋白质能量消耗 筛选及评估工具 maintenance hemodialysis protein energy wasting screening and assessment tools
  • 相关文献

参考文献5

二级参考文献48

  • 1α酮酸制剂在肾内科应用专家协作组.慢性肾脏病蛋白营养治疗共识[J].中华肾脏病杂志,2005,21(7):421-424. 被引量:134
  • 2季大玺,肖申,刘芸,黎磊石,刘志红,季曙明,任冰.无醋酸盐血液透析临床应用研究[J].中华肾脏病杂志,1995,11(1):16-19. 被引量:10
  • 3刘莉,杨莉,王梅.非糖尿病性终末期肾病患者透析时机的变化——2001年和2006年的比较[J].中国血液净化,2007,6(5):242-245. 被引量:15
  • 4Mineshima M,Ishimori I,Sakiyama R.Validity of internal filtration-enhanced hemodialysis as a new hemodiafiltration therapy[J].Blood Purif,2009,27(1):33-37.
  • 5Susantiaphong P,Tirnathanagul K,Katavetin P,et al.Efficacy of convective-controlled double high-flux hemodiafiltration versus on-line hemodiafiltration:1-year prospective study[J].Blood Purif,2010,29(1):35-43.
  • 6Fissell WH,Humes HD,Fleischman AJ,et al.Dialysis and nanotechnology:now,10 years,or never?[J] Blood Purif,2007,25(1):12-17.
  • 7Attaluri AC,Huang Z,Belwalkar A,et al.Evaluation of nano-porous alumina membranes for hemodialysis application[J].ASAIO J,2009,55(3):217-223.
  • 8Ronco C,Breuer B,Bowry SK.Hemodialysis membranes for high-volume hemodialytic therapies:The application of nanotechnology[J].Hemodial Int,2006,10(s1):S48-50.
  • 9Stamopoulos D,Bouziotis P,Benaki D,et al.Nanobiotechnology for the prevention of dialysis-related amyloidosis[J].Ther Apher Dial,2009,13(1):34-41.
  • 10Stamopoulos D,Bouziotis P,Benaki D,et al.Utilization of nanobiotechnology in haemodialysis:Mock-dialysis experiments on homocysteine[J].Nephrol Dial Transplant,2008,23(10):3234-3239.

共引文献70

同被引文献63

引证文献7

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部